Markets · Asia · Tokyo

4503.T Astellas Pharma Inc.

¥2,248 -0.33%

Asia · Pharmaceuticals

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-0.33%

YTD

+35.20%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.06

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

¥2,280

¥2,248

VWAP (n/a)

—

Day high

¥2,287

Day low

¥2,229

Volume

5.5M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026

Yahoo Finance · Oct 6

Astellas Pharma Inc's Dividend Analysis

Yahoo Finance · Sep 29

ARTHEx Biotech Announces Appointment of Glenn P. Sblendorio as Chairman of the Board

Yahoo Finance · Sep 29

Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow

Yahoo Finance · Sep 26

Astellas lists 431K sf Northbrook HQ in possible sale-leaseback play

Yahoo Finance · Sep 24

Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer

Yahoo Finance · Sep 23

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell 4503.T. Try it in the Lab to size a position and see the risk.